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Abstract: 
In an ethnographic study conducted over thirty months in South Africa’s Western Cape 
Province ending in 2012, we explored ART adherence amongst almost 200 patients attending 
three clinics. This setting contained significant political, structural, economic and socio-cultural 
barriers to the uptake of, and adherence to, treatment.  Such barriers certainly impacted patient 
drug use and the labelling of clients as ‘adherent’ or ‘non-adherent’.  Yet, as our fieldwork 
developed, it became apparent that these labels also bore little relationship to the amount and 
regularity of drug consumption outside the clinic. Indeed, the people that we knew moved 
through these labels in ways that could not simply be explained by brute socio-economic 
circumstances, poor understanding of the functions of the drugs, or varying levels of family 
and community support, which themselves often changed over time.  This paper presents four 
on-going ‘patterns of adherence’, which are clearly discernible in the communities in which 
we worked.  Each pattern is demonstrated through the life of an ‘index patient’ whose case 
is seen to be representative of the range of experiences and practices observed under the terms 
‘adherent’ and ‘non-adherent’.  We argue that such terms are deeply contextual and, crucially, 
temporally situated. The complex intertwining of political, economic, socio-cultural, gender, 
and biological factors that constitute the lives of participants exists in time and we call for a 
focus on evolving lives in relationship to changing health systems that can follow (and respond 
to) such developments to better deliver both information and services.
Key words: ART adherence, community, health systems, socio-cultural barriers drug consumption
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Résumé
Dans une étude ethnographique menée sur trente mois dans la province du Cap occidental 
en Afrique du Sud se terminant en 2012, nous avons exploré ART adhésion parmi près de 
200 patients fréquentant trois cliniques. Ce paramètre contient obstacles politiques, structurels, 
économiques et socio-culturels importants pour l ’absorption et l ’adhésion au traitement. Ces 
obstacles certainement touchés usage de drogues patient et l ’étiquetage des clients comme 
«adhérent» ou «non-adhérent. Pourtant, comme notre travail de terrain développé, il est devenu 
évident que ces étiquettes portaient aussi peu de rapport avec la quantité et la régularité de la 
consommation de drogue en dehors de la clinique. En effet, les personnes que nous connaissions 
déplacé à travers ces étiquettes d’une manière qui ne pouvait pas simplement être expliquées 
par les circonstances socio-économiques brute, une mauvaise compréhension des fonctions de la 
drogue, ou des niveaux variables de la famille et le soutien de la communauté, qui se souvent 
changé au fil du temps . Ce document présente quatre en cours “motifs d’adhésion», qui sont 
clairement visibles dans les communautés dans lesquelles nous avons travaillé. Chaque modèle 
est démontré à travers la vie d’un patient de l ’indice ‘dont le cas est vu pour être représentatifs 
de la diversité des expériences et des pratiques observées en vertu de l ’adhérent »et de« non-
adhérent. Nous soutenons que ces termes sont profondément contextuelle et, surtout, située 
temporellement. L’enchevêtrement complexe de politique économique socio-culturelle, de genre, 
et les facteurs biologiques qui constituent la vie des participants existe dans le temps et nous 
appellent à une mise au point sur l ’évolution de la vie dans la relation à l ’évolution des systèmes 
de santé qui peuvent suivre (et de répondre aux) tels développements pour mieux offrir à la fois 
des informations et des services.
Mots clés: ART adhésion , la communauté, les systèmes de santé , les barrières socio- culturelles 
la consommation de drogues
Introduction
This paper traces actual antiretroviral (ARV) usage in the lives of people living with 
HIV in situations of often-extreme structural violence, alongside their relationships 
to the medico-bureaucratic labels that form the portal to their life-saving medication. 
We centre our observations and analysis on the moving interface between clients and 
clinics, a membrane where multiple agencies and logics – in the shanty, in the clinic, 
and indeed globally - intersect over time, but which are usually tracked in a series of 
snap-shots, reducing them to seemingly clear categories of ‘adherent’, ‘non-adherent’ 
and ‘lost to follow-up’.  Such labels are not trivial, as they position individuals in 
ways that impact everything from their continuation on these drugs to understanding 
the effectiveness of treatment at regional, national, and global levels. At the same 
time, these labels are not simple: they shift over time and with respect to scales of 
analysis. Crucially, the same label can also cover very different patterns of actual drugs 
usage, while similar patterns of partial usage are sometimes discriminated through 
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different labels. We conclude that this complexity requires much closer ethnographic 
and theoretical attention and we suggest that the interface between the clinic and 
community should be the focus of this attention.
We start by locating some of the larger discussions of adherence in powerful 
discourses that provide funding for programmes and survey their results.  In doing so, 
we chart some of the complexities of surveillance and reporting categories upon which 
so many lives ride.  We then chart in our own work some of the ways that distinct 
lines are drawn between very similar patterns of the use of these medications while 
at other times very different patterns of use appear in the same category. At the same 
time, we reveal surprising levels of movement between seemingly neat categorizations 
that eventually code (in clean statistical tables projected in well-appointed conference 
rooms) the impact that these drugs are having. It is only when snap-shots are put back 
into social motion that can we see how important time is in understanding this complex 
social-medical situation. We offer this analysis not as a critique of global antiretroviral 
treatment (ART) policy, but as an encouragement for ethnographers to engage more 
directly the temporal aspect of ART, especially as reinvigorated focus on health systems 
is emerging as a significant issue in Public Health and Global Health.
Background
While the history of the struggle to gain popular access to antiretroviral treatment 
(ART) in the Republic of South Africa is well known in the literature, it still seems 
useful to review some of the highlights of this success here.  After sustained pressure 
from civil society organizations and the breaking of the Northern-held patent on 
antiretroviral (ARV) medication in 2001, the South African cabinet committed the 
government in 2003 to a public sector antiretroviral treatment ART rollout. By the end 
of 2013, over 2.5 million people were receiving ART (SA Dept. of Health, 2013-2014), 
and South Africa is now widely acknowledged to have the largest and best-established 
antiretroviral treatment programme in the world.
Since the 2003 rollout of ARV medication in South Africa, HIV has for many people 
changed from being a fatal disease to becoming a manageable chronic illness (Mitchell 
& Linsk, 2004). However, the successful management of this chronic illness is strongly 
dependent on the patient’s adherence to ARVs. An optimal adherence rate of 80-95% is 
required if medication is to be successful and the desired outcome – slowing the progression 
of the illness and decreasing morbidity and mortality rates from secondary infections – is 
to be achieved (Garcia & Cote, 2003; Battaglioli-DeNero, 2007; Shah, 2007; Ingersoll 
& Cohen, 2008). Sub-optimal adherence to antiretroviral treatment can cause treatment 
failure and, potentially, drug resistance, so we observe a wide variety of interventions in 
Public Health to assure as full adherence as possible in a population using ART.
Western Cape Province, in partnership with Médicins Sans Frontières, launched the 
first highly active antiretroviral treatment (HAART) program in May 2001 in defiance 
of national policy (Naimak, 2006). By March 2003 the province announced that all 
HIV-positive pregnant women could access the antiretroviral drug, Nevirapine, at their 
nearest clinic. The current HIV prevalence in the province is 18.2% (approx. 1,055,600 
people) (http://www.avert.org/south-africa-hiv-aids-statistics.htm) with a reported 
156,703 patients in the province receiving ART at the end of 2013 (Western Cape 
DoH 2014: 212). 
ART suppresses the virus and reduces viral replication to undetectable levels, turning 
a disease that had once been rightly feared as a death sentence into a chronic condition, 
potentially granting decades of life. However, in order for the treatment to be effective, 
a high rate of treatment adherence is required. The consequences of non-adherence, 
at the individual level, are a faster progression to full-blown AIDS, a much more 
expensive treatment regimen as other drugs are prescribed to stem the rising viral load, 
and potentially treatment failure and death.  The Public Health fear is that incomplete 
adherence on a large scale could potentially produce very resistant strains of HIV, 
reversing the remarkable success story in the control of this plague in the last twenty-
five years. Thus, the massification of ART resulted in increasing research on how to get 
people to become and remain ‘adherent’, and programme effectiveness is judged by the 
proportion of people who inhabit this category.
Adherence as an Optic and a Goal in Global and Public Health
From the innovation of HAART in the early 1990s, adherence emerged as a key health 
and policy issue.  Patients needed to take their medication exactly as prescribed, while 
also following the necessary dietary restrictions. The 2003 World Health Organisation 
report - Adherence to Long-term Therapies: Evidence for Action states that adherence is 
not only about taking medication properly, but also about behaviour, including arriving 
for appointments at the healthcare facility. Thus adherence is defined as ‘the extent 
to which a person’s behaviour - taking medication, following a proper diet, and/or 
executing lifestyle changes - corresponds with agreed recommendations from a health 
care provider’ (2003: 17).  Therefore, adherence is also closely linked to the issue of 
accessing medication and using it properly, even if it is not completely co-terminus 
with drug use (Reif et al, 2005). Indeed, for many people in need of ART, the process 
of accessing health facilities still serves as a great barrier to adherence (Reif et al., 2005; 
Tuller et al., 2010). 
After the breaking of the Northern patent on ART and the massification of this 
therapy, adherence emerged as a global concern, as funders and Global Health decision-
makers searched for ways to measure impact and understand unmet needs. This added 
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another definitional layer around “adherence”. For example, “full coverage” is defined 
by the WHO as getting ART to 80% of those in need in a population.  The data from 
four-year follow-up studies throughout the world, however, shows that adherence 
‘trajectories’ tend to track downwards over time, with adherence rates after four years 
falling to around 70% at the end of most of these studies (UNAIDS, 2012). In other 
words, in most resource-constrained settings, almost half of the people who might 
imagine themselves to have access to this form of therapeutic citizenship still do not 
(or have fallen out of this status) after only four years in populations deemed ‘adherent’.
These disparities present disquieting theoretical challenges, as scholars try to tease 
out ideas of discipline, medical necessity, and various understandings of agency in 
radically different settings, with literally life-and-death stakes in play.  In this debate 
“adherence” jostles with seeming synonyms, such as “compliance” to mark out different 
understandings of how the life-world of patients relates to ART.  Historically, some 
studies argued that adherence is the same as compliance (Shah, 2007; Ingersoll & 
Cohen, 2008), while others (Kaijee & Beardsley, 1992; WHO 2013) argue that the 
two are entirely different concepts, with ‘adherence’ being the more appropriate term. 
Kaijee & Beardsley (1992), on the other hand, point to the medically defined concept 
of ‘compliance’ as uni-dimensional and as a failure to recognize the patient’s agency. 
WHO (2013) argues that while the relationship between the healthcare provider and 
the patient must be a partnership during which the treatment process is discussed, 
‘compliance’ implies that patients are passive participants in their treatment process, and 
does not acknowledge the necessity of such a partnership.  
Maskovsky (2005) also challenges this emphasis on ‘adherence’ rather than 
‘compliance’, which he argues ‘places the burden – and much of the blame – for the 
failure of HIV drugs on the people who take them’ (see also Mattes 2015).   As 
Crespo-Fierro (1997) notes, the reasons for non-adherence are generally multifaceted. 
Factors that negatively impact on adherence to ART are generally categorised into 
four groups - disease-related, patient-related, provider-related and treatment-related 
(WHO, 2003; Hardon, et al, 2007; Bardel et al, 2007; Spire et al, 2002; Hubbard, 
2006). Linguistic and communication factors, such as those highlighted by Penn et al 
(2011) have also been pointed to as issues in adherence. There is also the significant 
issue of the political economics of access (Nattrass, 2008) or the political decision-
making processes that place voter interests ahead of patient need (Bruera 2006) in the 
distribution of scarce resources. 
We also have detailed ethnographies of people with HIV trying to access treatment, 
and indeed health, in extremely trying circumstances (see especially Biehl 2007, Zigon 
2010). In such work, however, the clinic is constructed as a semi-opaque bureaucratic 
structure, and we are unclear how the messy complexities we see in the ethnography 
are structured into the reporting categories that inform donors and international 
health organizations of the effectiveness of their interventions, while the ethnography 
beautifully (if tragically) documents often very partial adherence.  In other words, the 
question is not just the ‘limits of surveillance’ in Biehl’s apt phrasing (2007:179-180), 
but also understanding the specific means through which surveillance as such is enacted 
in particular times and places in relationship to actual patterns of drug use.
Factors Explaining Non-Adherence
Disease-related factors
Adherence to medication is poor when the illness is asymptomatic and chronic. 
Advanced illness as well as exposure to painful symptoms and side effects may result in 
a greater likelihood of the patient following the treatment as prescribed (Abel & Painter 
2003, Battaglioli-DeNero 2007, Gay et al 2010). In one American study, disease severity 
was identified as playing a key role in adherence, as patients who have experienced 
complications from the disease may believe that they are at greater risk of their disease 
getting worse if they do not adhere to ARVs (Gao et al, 2002). On the other hand 
rumours of bad side-effects discourage attendance among some (Grant et al 2008) while 
in the South African context, early political equivocation regarding lay and untested 
HIV remedies led many to explore these options instead of, or alongside, their ART 
treatment (Mills 2008).
Patient-related factors
Acceptance and disclosure of the disease facilitates support from family and friends, 
which can impact positively on adherence (Battaglioli-DeNero 2007). Culture, religion, 
health beliefs, health practice and motivation can have both a negative and a positive 
impact (Ezekiel et al. 2009, also Russell and Seeley 2009). Kalichman et al (2005) 
identified the need to develop the adherence skills of patients, and provide devices or 
strategies to help adherence. Failure to fill prescriptions, missing and forgetting doses 
(Katzenstein, 1997), incorrect dosing and self-regulating the regimen to manage side 
effects are additional negative factors (WHO, 2003; Hardon et al, 2007; Nam et al, 
2008). Other factors identified, which contribute to poor adherence, were stigma, 
hunger, transport cost (accessing healthcare facilities) and substance abuse, including 
alcohol consumption (Reif et al, 2005; Conen et al, 2009; Hardon et al, 2007).
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Methodology
We worked over a period of 30 months from 2009, in the West Coast region of 
Western Cape Province (Saris et al, 2012). The three ART clinics that form part of 
this study have a catchment area of approximately 450km, with a population of close 
to 500,000.  In June 2009 those three clinics combined had 1,212 people (1126 adults 
and 86 children) attending for antiretroviral treatment (Western Cape DoH, personal 
correspondence, June 2009). Province-wide during 2009 approximately 2,500 people 
were being initiated onto antiretroviral therapy per month, and it was anticipated that 
this number would need to be maintained for 3-5 years (Western Cape DoH Annual 
Performance Plan 2011/2012).
In addition to the three ART clinics, our research site included ten referring primary 
health care clinics (PHCs), five Non Governmental Organisations (NGOs) who provide 
outreach services, and the homes of numerous people on ART.  Outreach staff were 
instrumental in introducing us to HIV-positive participants who were not attending 
the clinics and therefore were deemed ‘non-adherent’, so we had regular access to some 
patients that the clinics themselves wanted to bring closer. In other words, our team 
had a presence in all of the formal clinical settings people accessing ART could attend 
as well as having a presence in their homes and local communities.  Thus, we were able 
to follow not just people, but also information and objects (especially pharmaceuticals), 
repeatedly across the interface between the clinic and the community.
Patient participants were recruited through both convenience and purposive sampling 
at ART clinics or through outreach workers in the community. In addition to patients, 
a total of 36 health worker participants (doctors, nurses, pharmacists, support staff, 
outreach workers, etc.) were purposively selected on the basis of their stakeholder status 
and their ongoing interaction with patients. The principles of written informed consent 
were applied in all cases. 
Ethical approval was obtained from the Western Cape Provincial Department of 
Health, from University of Western Cape, South Africa and from Maynooth University, 
Ireland. Permission to engage with ART and PHC clinics was gained from the Regional 
Director initially and from each individual hospital/clinic/NGO.
Methodological, data and investigator triangulation processes (Guion, 2011) were 
adopted, to ensure validity of data.  Initially patients consented to one-to-one, semi-
structured interviews in their language of choice2.  Once an initial interview was 
complete, all participants were asked for further permission to continue engagement 
with them. For patients attending an ART clinic this involved a researcher who 
‘shadowed’ them during interactions with the various health professionals (doctors, 
2  Of the eleven official languages in South Africa, Afrikaans, English and isiXhosa are the official languages of 
Western Cape Province.  All of our research team are fluent in at least two of the three official languages.
Provider-related factors
In attempting to address adherence, studies often focus on patient-related adherence 
factors rather than provider-related adherence factors. With the increased prevalence of 
HIV, healthcare systems have become overworked and understaffed. This has resulted 
in a lack of counselling expertise and time to counsel patients properly. Linguistic 
barriers may impede communication of treatment regimen; therefore language and 
literacy issues, particularly in multilingual sites such as Western Cape, are often seen to 
impede the provision of equitable care (Deumert 2010, Penn et al 2011). Where there 
is ART regimen complexity providers need to tailor regimens to individual lifestyles 
(Battagliolo-DeNero 2007). An overestimation of adherence readiness and willingness 
may result in inaccurate adherence predictions, as patients may not fully comprehend 
their regimens (Ingersoll & Cohen, 2008). 
The quality of healthcare provider (HCP) communication with the patient, is an 
important determinant of adherence (Abel & Painter 2003, Hargie 1999, WHO 
2003); and thus of the actual therapeutic process and behaviour. Tugenberg et al. (2006) 
found that patients’ relationships with HCPs played an important role in patients’ non-
adherence and the disclosure thereof. Participants in this Massachusetts-based study 
confirmed that the emphasis and ‘insistence’ on adherence sometimes had the opposite 
effect, and that non-adherence is often not disclosed due to concerns of being seen as 
a bad patient or to avoid being reprimanded. Lack of disclosure of non-adherence was 
also a way to avoid ‘disappointing’ the HCP (Tugenberg et al, 2006).  
Treatment-related factors
Poor adherence can be due to the complexity of the regimen, dosing times and the 
number or variety of pills the patient has to take (Battagliolo-DeNero, 2007; Gallant, 
2002; Ingersoll & Cohen, 2008). Generally, if a dosing schedule that coincides with daily 
routine has not been planned and implemented, difficulty in adherence to treatment is 
likely to occur. 
Thus, adherence has a dual quality in the literature; that is, it exists as both a state 
and a process (Gray 2006). Patients’ lives can display, at different times and in different 
circumstances ‘erratic non-adherence’, ‘unwitting non-adherence’ and ‘intelligent non-
adherence’ (Donovan & Blake 1992), but at any moment in time there are a very limited 
number of ways to view and tabulate these patterns. To this extent, it seems that a much 
more serious engagement is required with the relationship between temporality, actual 
use of medication, and the clinical gaze.
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All participants have been anonymised and pseudonyms applied.
Benjamin’s story, RIP (Adherent - Lost to Follow-Up): 
The ‘treatment holidays’ patient (six months on/six months off, or nine months on/
three months off )
28 year-old Benjamin was wheelchair bound when we were first introduced at an 
ART clinic; extremely weak and frail, he was living at his mother’s home in the West 
Coast region. Benjamin had attended primary school but his family could not afford his 
attendance at secondary school. We subsequently met with him at his mother’s home 
and at the clinic on numerous occasions.
Benjamin tested HIV and TB positive nine years previously, and was successfully treated 
for his TB before beginning antiretroviral treatment for HIV. His treatment initially 
caused upsetting side-effects - a rash on his chest, under his arms and on his private 
parts, and lumps on his leg, under the skin.  No medication was made available to him 
for the side effects but his mother treated these with ointment and he persevered with 
his ART and slowly began to feel better. For Benjamin, as for others we spoke to, it was 
when he started feeling well again that he stopped taking his medication. Travelling to 
the Northern Cape Province he found temporary work until his condition deteriorated 
and he sought treatment at a local clinic.  Unfortunately for reasons that were unclear to 
Benjamin, his initiation onto second line treatment was delayed in the Northern Cape 
continuously and in desperation he returned to the West Coast district where he had first 
been treated in the hopes of receiving second line treatment.  This is where we met.
In the year after our initial meeting, Benjamin’s progress on treatment was sporadic.  His 
weakened condition made eating difficult and he was given nutritional supplements to drink 
with his medication. He was admitted to an isolation ward in hospital for five days after 
again contracting TB, although thankfully not a drug-resistant form.  He was also diagnosed 
with epilepsy and was being treated for this condition while continuing on ART.  Over 
the time we knew him, Benjamin reported feeling better and gradually was able to move 
about without his wheelchair.  Under his mother’s care, and with the clinic’s assistance, his 
condition improved, although he remained silent, withdrawn and extremely thin.  
Suddenly we received news that Benjamin had once again left the district to return to 
the Northern Cape.  The staff at the clinic expressed disappointment as they felt that, 
although improved, his condition was not stable enough to once again leave their care, 
but he had not consulted with them before he left.
For reasons that are unclear, Benjamin once again stopped taking his ARVs when he 
got to the Northern Cape.  We received word that he had passed away approximately 
one year after our first meeting.
Understanding Benjamin
A number of issues arising out of Benjamin’s story have a bearing on his adherence 
pattern. While living under the close scrutiny and vigilant care of his mother, 
Benjamin’s condition improved.  Indeed, because of the social support available 
nurses, pharmacists, ART counsellors, etc.)3.  This facilitated observation and recording 
of patient experiences as they moved through the treatment pathway. Participants who 
were not engaged with services were asked to continue speaking to our researchers at 
their own discretion. Many patient participants gave permission for multiple follow-up 
meetings and shared their stories with us through conversations and interviews either at 
the clinic, at their homes, or at a place of their choice. 
All formal interactions were digitally recorded, transcribed in full and, where 
appropriate, translated into English, which was the working language of all team 
members.  A portion of the transcriptions were also then back-translated from 
English to Afrikaans or English to isiXhosa for verification of the translation process. 
Researchers had the opportunity to observe daily activities at each of the clinics over a 
number of months, and these were recorded in field diaries, which, along with interview 
notes, formed part of the data set.  A thematic analysis was then conducted using cyclic 
three-step analysis - open coding, followed by axial coding, followed by selective coding 
(Strauss and Corbin, 1990) and AtlasTi was used to manage data sets.  Finally, 22 ‘index 
patients’ were identified whose cases typified the broader patient base in terms of their 
(non)adherence patterns. Four clear patterns emerged which were developed into brief 
representative case studies.
Once these representative case studies were completed a series of workshops was 
held where our data and provisional conclusions were presented to a cross section of 
participants (patients, health workers and NGO staff ). This allowed participants the 
opportunity to give feedback about the findings, and to contribute to the interpretive 
process.  Each of the patterns presented below was endorsed as an accurate representation 
of the lived experience of HIV-positive patients in the region.
Patterns of Adherence as Ethnographic Data
The case studies below are drawn from the 22 index patients, which were chosen as 
representative of patterns of adherence amongst our participants.  They demonstrate 
the complex intertwining of political, economic, social-cultural, gender, and biological 
factors that impact the experience of living with HIV, as well as access and adherence to 
treatment. Many of these barriers cannot always be so clearly delineated, as they bleed 
into and influence each other.  Others clearly have a top-down or bottom-up impact 
on how services are provided and on how service users access and understand their 
treatment.  In concrete social-historical circumstances, these factors meet at the interface 
between logics and optics in the clinic and the resource constraints, expectations, even 
the resilience of real people.  This interface exists in time, however, and very often the 
same behaviour, object, or idea changes its valence, sometimes dramatically, while people 
negotiate their relationship to different bureaucratic categories.  
3  The healthcare worker’s permission was also requested in such instances.
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for the ease of transfer of patients between facilities, even within the same district, 
because much of the patient information is still only in paper format (patient registers 
and folders).
Benjamin’s recorded status with the clinic moved from ‘adherent’ to ‘lost to follow-up’ 
before word was received that he had passed away.
Gabriella’s Story (Non-adherent – Adherent)
The ‘partying’ patient (six days on/one day off )
Gabriella was a 42-year old woman born in a rural part of the Northern Cape Province. 
She attended school there until the age of 10, but migrated to Western Cape in 1997 to 
find work. Her home was a shack in an informal settlement about 3km from her local 
ART clinic, where she lived alone. She had limited contact with her adult children who 
had moved away from her since discovering her HIV positive status.   
Unemployed, Gabriella sometimes had casual work as a domestic servant for a few 
hours a week.  Friends and neighbours offered food or money but she was reluctant to 
receive favours, preferring to do some small amount of housework for them rather than 
accept charity.  Her absent boyfriend sent money erratically.  When we first met it was 
4pm in the afternoon and Gabriella had not eaten since breakfast the previous morning.
Gabriella became emotional as she recounted in vivid detail how she received her 
diagnosis for ‘this illness’.  Herself and her boyfriend both tested positive at the same 
time in 2008.  ‘They came back with coffee and two slices of bread’ she said ‘and the 
doctor came and looked at me...gave me a letter...told me that I am HIV positive’. Three 
months later, with a CD4 count of 145 cells/μl, Gabriella was started on ARVs.  
Anxious to assure the researcher that she understood her treatment regimen, Gabriella 
took her tablets out of her bag to show which ones are taken at which times of day. 
The pills were muddy, as though they had been dropped or handled repeatedly.  We 
established that adherence has not always been ideal and that Gabriella’s pattern of 
adherence had changed substantially over the 18 months since she began treatment.
• Severe side effects (sore body, itching, dizziness, double vision, night sweats) 
in the early stages of treatment caused Gabriella to stop taking her medication 
properly.  These side effects continued even after medication had been prescribed 
to relieve symptoms.
• At one stage Gabriella felt life wasn’t worth living because her children didn’t want 
to know her and she felt they didn’t care, so she stopped taking her medication for 
a month. Gabriella went back on the treatment when she began to feel really sick.
• Numerous medical staff instructed Gabriella not to drink alcohol while taking 
her medication. Therefore, when she partied, or planned to drink, she did not take 
her medication. Nor did she take a double dose the next day; just skipped a dose. 
to Benjamin, through his mother’s care, the clinic were more inclined to provide 
additional assistance – they arranged to have his medication delivered to a clinic closer 
to Benjamin’s home, and they provided nutritional supplements to Benjamin that 
were not given to other patients. 
Once his condition improved, however, Benjamin repeatedly left his mother’s care 
to return to his life in Northern Cape.  Once there, he did not/could not access 
medication and his condition would deteriorate. Lima et al (2008) found that 
individuals migrating at least three times were 1.79 times more likely to be non-
adherent than individuals who did not migrate.
It is not uncommon for patients to stop taking ARVs when their condition 
begins to improve.  While medical staff stress that there is no cure for HIV, this 
is a problematic notion for some.  This may relate to a straightforward matter of 
translation as for some local languages the word for ‘treat’, ‘heal’ and ‘cure’ is the 
same, and the distinction that is made in English does not translate properly. But the 
concept of a non-curable disease is also problematic, as Murray et al (2009) found in 
their study amongst Zambian women.  Why should one continue to take medication 
if one is ‘better’?  For these patients, it is not until their condition deteriorates 
again (some months later) that they realise they need to go back to treatment.  Nor 
is it particularly uncommon for this cycle to be repeated, deliberately or through 
unavoidable life circumstances. Such ‘treatment holidays’, when unplanned, can 
result in the emergence of HIV isolates resistant to ARVs (Katzenstein, 1997).
The inequity in treatment facilities in various parts of the country also has a bearing 
on Benjamin’s adherence.  The ART rollout programmes in the Western Cape and 
Gauteng provinces are renowned countrywide for being efficient and effective. 
Internal migration for treatment purposes is not uncommon.  However, patients 
regularly leave the district for up to three months at a time (for seasonal farm work, 
during holiday periods or to attend traditional family events) and are often unable 
to access elsewhere the high levels of treatment they have come to enjoy in Western 
Cape.  This poses difficulties for the clinics in each district.   Western Cape clinics 
are reluctant to provide patients with bulk medication for an indeterminate period, 
unless they have established an exceptionally good working/treatment relationship 
with the clinic.  For the clinic in the host communities, these ‘visiting’ patients can 
often not be accommodated because of lack of resources, shortages of medication, 
insufficient medical histories, etc.  
Further challenges arise for patients who wish to transfer to another health facility 
when life circumstances change. These moves could be in pursuit of employment 
opportunities, forced by changing home situations, or simply wanting to start afresh 
with the new lease of life received from successful treatment. Whereas a province like 
the Western Cape has a well-resourced health system and boasts a computerised district 
health information system, the reality on the ground is that this system does not allow 
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The clinics in the Western Cape use a ‘teach back’ technique to inform their patients 
in an effort to ensure that the patient is not a passive recipient of knowledge, but an 
active participant in the treatment process.  This requires that the patient repeat back 
to the counsellor the information he or she has received, in order that the counsellor 
can see whether they have received the information correctly. Watermeyer & Penn 
(2008) describe the same process being used amongst pharmacists dispensing ARVs 
in Johannesburg. However, the manner in which patients repeat (verbatim, and with 
gestures) the information they have been given about alcohol avoidance, suggests that 
they do not fully comprehend the reason for avoiding alcohol.  While alcohol is central 
to social life in the area, there is little tolerance on the part of health workers for even 
moderate alcohol use. One of our researchers witnessed an adherence counsellor refuse 
to recommend a patient for treatment on the basis that her husband drank alcohol. 
Gabriella only drank on Saturday nights, but was said she was ‘afraid’ to take her 
medication when drinking because she had been told it was ‘very very bad’.  Instead, 
as is the case with many others, her pattern of adherence was to take medication from 
Sunday to Friday only.
Gabriella was initially recorded as non-adherent, but, later, with little change in her 
drug-routine, she was labelled adherent.
 
Neville’s Story (Adherent)
The ‘playing’ patient (5 ½ months on/two weeks off )
38 year-old Neville lived in his sister’s home close to one of the ART clinics when 
we first met. He was introduced to two of our researchers by outreach staff who were 
concerned about his adherence. Both his parents were deceased and he had no partner. 
His sister had taken him in but their relationship was not good and money worries 
added to the difficulties.  Having tested HIV and TB positive in 2008, Neville was 
granted a temporary (six month) social grant, which was due to end within 3 months 
of our meeting. This was a cause of enormous concern for Neville who repeatedly 
asked for help with retaining his grant. The grant paid for bills for himself and his 
sister and sometimes there was no money left for food.  He generally borrowed money 
for food and was concerned about what would happen when the grant finished.  His 
repeated question ‘Wat moet ek maak, wat moet ek maak?’ (What must I do?), lent an air 
of desperation to his conversation.  
Neville explained to us his treatment regimen. Taking a handful of tablets that he 
was carrying loosely in his pocket, he correctly identified the ARVs and explained 
(incorrectly) that he should take them at 12 noon and 7pm, and had already taken his 
TB meds at 7am this morning.  In fact ARVs should be taken at 12-hour intervals and 
Understanding Gabriella
Gabriella’s case is typical of those patients whose adherence pattern changes 
considerably over the first year of treatment before settling into a less than ideal semi-
adherent pattern.  
No individual screening is conducted before initiation on first line ARVs to establish 
the potential extent or severity of side effects. Information regarding side effects is not 
always forthcoming, with Clinic counsellors and home-based carers expressing concern 
that patients will not take the medication if they know how severe the side effects might 
be. Instead, counsellors often ‘drip-feed’ information about side effects to patients as 
required, in the hope that they will not be discouraged.  Patients who do experience side 
effects may stop taking their medication completely without ever returning to the clinic 
again.  Where patients show willingness to persevere, the clinics will attempt to either 
treat the side effects, or provide alternative ARVs to reduce the impact.  In Gabriella’s 
case her pill burden increased substantially and the side effects were reduced, although 
not eliminated.
Depression and feelings of loss are not uncommon amongst patients given a diagnosis 
of HIV.  As family relationships broke down, Gabriella stopped taking her medication 
because she said she ‘wanted to just die’.  Ammassari et al (2004) and Battaglioli-DeNero 
(2007) report on the negative impact of depressive symptoms on ART adherence. 
Ironically, Gabriella reported that it was after she stopped taking her medication and 
her condition deteriorated substantially, that her daughter began to re-engage and they 
started to mend their relationship.
Gabriella’s pattern of adherence is extremely common amongst patients in the 
Western Cape region.  Patients are repeatedly told that they should not drink while they 
are taking ARVs. There are several reasons for this: ARVs have the potential to cause 
liver toxicity and this is exacerbated by alcohol abuse; excessive alcohol consumption 
may increase the risk of non-adherence as people forget to take their medication, or 
the affects of the alcohol (or indeed recreational drugs) can inhibit the effects of ARVs. 
However, it is generally accepted internationally that failing to take a dose of ARVs, 
or erratic adherence, can cause more harm than taking ARVs with alcohol.  Many of 
the nurses and counsellors currently working with HIV patients would previously have 
been trained in TB care, which requires that patients remain completely alcohol-free 
while taking their medication. This instruction appears to have been carried over to the 
treatment of HIV. Also, given the region’s difficult history with alcohol and the high 
rate of alcohol abuse and foetal alcohol syndrome (FAS) amongst the local population 
(McKinstry 2005, London 2000, Olivier et al 2013), there is a genuine antipathy 
towards any alcohol use amongst many of the healthcare staff, and particularly nurses, in 
local clinics. Finally, the information currently provided to patients regarding ARVs and 
alcohol consumption could be interpreted as a medical care rationing decision on the 
part of the Government, rather than a decision based on clinical outcomes. 
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grant.5  The most common form of ‘playing’ with medication in such situations is to take 
pills only every second day; or to stop taking them completely in the days coming up to 
a blood test.  The clinic checks adherence based on a medication count conducted during 
the normal check-up, but medication counts ignore medication complexity (Libby et al 
2013) and do not confirm that a patient has in fact consumed the medication; merely 
that he/she has removed the medication from the package.  We found patients in 
extreme circumstances will throw their medication away, flush it down the toilet or (in 
one case) keep it safely in a separate glass on a dresser.
Neville’s attendance at a variety of different healthcare settings also served to confuse 
him with regards to his medication.  The local ART clinic that Neville attended had 
considerable difficulties with retention of medical staff in the previous two years.  This 
is in large part due to a systems failure within the organisational structure of the rollout 
programme of the district.  The result is that over a six-month period in 2009 there were 
five different doctors in the clinic and for long stretches of time the clinic had no doctor 
at all.  Over the period in question the clinic staff reported that up to 100 patients had 
been ‘lost to follow-up’.  Local newspapers carried reports from patients who expressed 
their concern at the breakdown in service at this clinic, and many patients sought 
services at clinics in neighbouring jurisdictions.  The failure of the clinic service itself 
presented a barrier to adherence for the patients in this instance.  Neville was caught up 
in this situation, unable to find a doctor who could cater for all his needs and receiving 
contradictory information regarding his treatment regimen.  
Poor service delivery, low levels of treatment literacy, an extremely complex treatment 
regimen and the withdrawal of a social grant resulted in a lack of adherence for Neville. 
A pattern of adherence that was good for five and a half months, then poor for a few 
weeks, resulted and is typical of people ‘playing’ with meds in an attempt to retain a 
social grant.
Neville was recorded as being adherent by the clinic.
Ophelia’s Story (Non-adherent – Adherent)
The ‘secretive’ patient (skips two or three doses of medication per week every week)
Our isiXhosa-speaking researcher first met Ophelia at her home having received prior 
permission to call via an outreach worker.   Ophelia was a 41 year-old woman who lived 
with her boyfriend and her daughter in an informal settlement about 1km from one of 
the clinics.  She was unemployed and had no income.  Ophelia’s older child lived away 
from home and had menial work but was not in a position to provide any financial 
assistance to her mother.  Ophelia relied solely on food parcels from the local home-
based care centre, and handouts from friends.   She tested HIV-positive in 2007 and she 
had not disclosed her status to her partner because she believed him to be HIV-negative. 
5  For more on this see Nattrass (2004) ‘Trading-off income and health: AIDS and the 
disability grant in South Africa’.
the TB meds can be taken separately.  He was also taking medication to counter side 
effects of the ARVs and had been told to continue taking it although he said it didn’t 
work.  It soon became apparent that Neville was attending three clinics in three different 
jurisdictions, though he could not clearly explain why this was the case.  It appeared that 
one clinic was treating his HIV, another his TB and the hospital was treating Neville 
for cancer.
As we met with Neville over the following months, his situation deteriorated rapidly. 
The relationship between himself and his sister broke down completely and he was now 
living alone. He struggled to get money but sometimes got a bit of gardening work, 
which provided intermittent income. In addition, the hospital he had been attending 
had confirmed a diagnosis of cancer, but Neville was unable to provide any further 
information on this.  His social grant was not renewed and the letter he received (which 
we were shown) did not explain why. He was given leave to appeal the decision of the 
SASSA (social welfare) and was planning to do so with the help of an outreach worker.
Understanding Neville
When patients are initially put on ART they most often present with a WHO Stage 
III HIV illness, i.e. they had at that time (pre 2010) a CD4 count of ≤200 cells/μl.4 
Patients are informed that they qualify for a grant as they are medically unfit to work. 
The CD4 count in itself does not render a patient medically fit/unfit to qualify for a grant. 
However, those with low CD4 counts in most cases experience a decline in their health 
– hence the reporting to the health setting. It is this concomitant factor that leads to the 
physician motivating for the disability grant on the basis of HIV defining illness. As the 
importance of the CD4 count is impressed on the patient in a variety of settings they 
come to believe, with some justification, that a CD4 count of ≤200cells/μl is the measure 
that determines their eligibility for a welfare grant. Patient CD4 count is checked every 
three months.  It is envisaged that this check would indicate whether current treatment 
is working; soon after ARVs are instituted CD4 counts can be expected to rise and 
viral load reduced so low as to be undetectable.  An increase in CD4 count would 
indicate that the person’s immune system is getting stronger and HIV viral replication 
is suppressed.  A stronger immune system would also indicate that the person is getting 
stronger (and potentially on the way to becoming economically productive). 
The timing of a CD4 count blood test generally coincides with the renewal date of a 
social grant.  For some patients, the grant has become a de facto poverty alleviation grant 
and they are unable to cope financially without it.  They therefore begin to ‘play’ with 
their medication, in an attempt to ‘manage’ their CD4 count and thus retain their social 
4 In July 2014 the National DoH changed its national guidelines to raise the threshold 
for initiation of ART at a CD4 count of ≤500cells/μl, effective January 2015. (SA 
DoH, 2014: 14). How this will impact patient’s perception of their access to the grant is 
something that should be followed.
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refusing to take her medication as a protest, although since she struggled to articulate 
this clearly her protest went unnoticed.  
Publicly berating patients for non-attendance or poor adherence behaviour is a 
common occurrence in ART clinics. Our researchers have been present when patients 
have been shouted at and while clinic staff have conducted telephone conversations 
with patients, using their name and personal details, all within view/earshot of a full 
waiting room.  Lack of attention to issues of confidentiality has also resulted in patient 
files being left open for other patients to see and, in one extreme case, a patient berated 
continuously for non-adherence because the clinic had confused her with someone else 
of the same name.  The breakdown in trust and resulting poor relationships have a 
bearing on adherence as patients will often refuse to attend after such an incident, for 
fear of receiving another public rebuke.  As one patient put it ‘She tells me I will die... 
Just die!  I know I’m going to die but sometimes I have a problem.’
Finally, the fear of disclosure to a partner, workmate or other family members often 
causes patients to skip their medication rather than take it in view of others.  One of 
our participants skips his medication once a week, when working on a specific shift with 
what he considers a suspicious co-worker.  Conscious of the rattle of medication in a 
plastic pillbox, many patients prefer to carry their pills in plastic bags or loose in their 
pockets rather than have their status ‘betrayed’ by rattling pillboxes. This often results 
in a degradation of the pills as they become dirty and/or chipped.  In cramped living 
conditions it is difficult to have secrets from loved ones and Ophelia’s decision to leave 
her medication elsewhere in order to maintain some confidentiality had an enormous 
bearing on her health.
Ophelia was originally reported as ‘non-adherent’ but, still only on a partial usage 
schedule, she was, by the end of our research, recorded as ‘adherent’ by the clinic.
The Membrane Between the Clinic and the Community
At one level, these four cases add to a well-established record in the literature on HIV 
and ART concerning the unhappy alchemy of how resource scarcity, different expectations 
of the clinical encounter, a conflicted political history, and ways that various elements (both 
physical and human) structure how patients come to therapy (as well as the expectations 
people have of this treatment) in local moral worlds. Once on medication, however, studies 
on the temporality of ART adherence tend to bifurcate, with those in the Global North, 
largely stressing the psychotherapeutic aspects of choice, such as ‘choosing life’ (Gray 
2006:52) or ‘sticking to it’ (Burton and Hudson 2001) or treating the co-morbid mental 
illness that interferes with decision-making (Daughters et al. 2010).  In the Global South, 
on the other hand, the challenges in front of adherence as a process still (understandably) 
tend to be situated in political economic constraints and how brutal limitations impact 
She had also been successfully treated for TB.  
When initially diagnosed, and before commencing ARVs, Ophelia suffered from 
ibande (shingles).  She described severe symptoms including pain and ‘itchiness on the 
inside’ and was given painkillers, sleeping tablets and calamine lotion by the clinic, none 
of which eased her condition.  She attended a traditional healer who gave her some muti, 
that she took in addition to her other medication, but the muti caused diarrhoea so she 
stopped taking it and has not returned to her traditional healer.  
Ophelia was prescribed Bactrim and Vit Bco, for three months during the work-up 
period for ARVs.  However, she left the jurisdiction of the clinic to attend to family 
matters in emaXhoseni  (Eastern Cape rural areas) and because of this was deemed to be 
a risk for adherence on ARVs when started.   
In an effort to convince the clinic to support her application for a disability grant, 
Ophelia threatened not to take her medication unless she ‘got the pay’.  Her grant 
was never processed due to a series of bureaucratic errors and Ophelia was particularly 
aggrieved that, despite a CD4 count of 4 (four) cells/μl, she still received no financial 
assistance from the state.
Once ARVs were initiated, side effects including nausea, vomiting and a rash were 
constant.   She attributed this to taking medication on an empty stomach but said when 
she told the clinic she had no food they didn’t care.   At the time of our first meeting 
Ophelia had not taken her medication properly for the previous two months.  This was 
in part due to the breakdown in her relationship with the clinic who publicly berated 
and humiliated her for not adhering to the treatment regimen pre-ARVs.  She was 
angered by their apparent unwillingness or inability to help with the grant application. 
The nausea and vomiting she experienced also discouraged her from full adherence.  In 
addition, in an effort to hide her status from her boyfriend, Ophelia kept her medication 
at the home of her older daughter and could not always get to her daughter’s home to 
collect the medication as required
Understanding Ophelia
A number of factors impacted on Ophelia’s adherence behaviour but her pattern of 
adherence was such that she missed/skipped her medication twice or three times per 
week.  
The grant application system presented bureaucratic obstacles impossible for Ophelia 
to overcome without assistance.  This assistance is often given by the clinic, but given the 
breakdown in her relationship with the clinic, such assistance was not forthcoming.  A 
series of errors with the application (no doctor’s stamp, a shortage of clinic letterheads, 
Ophelia’s inability to provide a utility bill) prevented it from even being processed 
despite the fact that she was clearly eligible under all the necessary criteria to receive 
funds.  Her resentment with this situation was such that, at one stage, she was partly 
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monitoring - such as the work of Boulle et al. in Khayelitsha - about 10% have been lost 
to follow-up and over 14% are on second-line therapy because of adherence issues with 
their first-line drugs (Boulle et al 2010). The Western Cape in the Republic of South 
Africa, while a resource-poor setting, is probably the most ‘developed’ infrastructure for 
HIV treatment on the continent: it is where most of the assumptions about ‘adherence’, 
birthed in the industrial economies of the North (shaky as they may be for marginal 
populations in those settings) should best work. It is very hard to understand how we 
continue to track the success of programmes that in less than a decade scaled up a 
treatment regimen that serviced thousands (in very specific parts of the world) to one 
approaching ten million (delivered in nearly every part of the world) (UNAIDS 2013, 
WHO 2013), through these three simple categories - ‘adherent’, ‘non-adherent’ and ‘lost 
to follow-up’ - when the fluid nature of such categories are part of the tacit knowledge 
of most researchers and clinicians in this field.  
Conclusion
Almost two decades after Farmer’s clarion call to understand, ‘the degree to which 
patients are able to comply with treatment regimens is significantly limited by forces 
that are simply beyond their control’ (2001 [1999]), researchers in Global Health, 
International Health, Medical Anthropology, and beyond have recognized that 
structural violence imposes brutal limitations on a notional standard average subject 
making rational choices to take their meds and get better.  Indeed, the term ‘structural 
violence’ has been absorbed into the working lexicon of practically all researchers in 
HIV and AIDS. Yet, after undeniable progress in tackling the plagues that were ‘new’ 
in the 1980s and 1990s, we find subjects and local moral worlds that are still resistant 
to easy comprehension or straightforward manipulation. To put it in perhaps more 
provocative terms: humans strive to regain (or help others regain) health, but not just as 
healers and sufferers please, and certainly not at a time and place of their own choosing. 
Resource scarcity and structural violence impacts individuals, families, and communities 
simultaneously but often in very different ways, even within the same neighbourhood. If 
treatment comes with an income supplement, for example, then its ‘success’ results not 
only in a now-healthier individual, but also in renewed distress of a family unit, even as 
a reinvigorated body emerges into a new horizon of local possibilities and limitations 
(see Mfecane 2012).  In a similar fashion, powerful drugs enter local moral worlds at a 
particular historical moment, bearing specific valences. In South Africa, as in most of the 
Southern roll-out of ART, they often come coded as gifts with all the social-building and 
social-imperilling qualities that this term entails. They also confront indigenous forms 
of pharmacological reasoning that are only crudely labelled ‘folk’ and ‘traditional’, often 
with unforeseen results (see Larkan, van Wyk and Saris 2010).  Yet, in the compiling of 
local notions of agency (for a review, see Brandt 2009; see also Siu et al. 2013 and Ezekiel 
et al. 2009 among many others).  Despite long-standing calls (and even announcements) 
to combine such approaches (e.g., Parker 2001) in HIV research, in the Global North the 
internal psychic economy is seen to be decisive in ART adherence and, in the South, it is 
generally the ways that the straitened material economy or the local cultural topography 
of gender and class inhibits choice.  In neither body of literature is the temporality of 
adherence to ART granted a decisive role in theory.  Thus, while we have in Anthropology 
strong critiques of abstract choice, there is still a hesitation to explore agency as a 
processional phenomenon that emerges (and alters) over time in concrete social-historical 
circumstances (for a considered exception to this statement, see Irving 2011).
The fluidity of these categories, of course, has real-world consequences for our 
understanding of ART.  In these four cases, for example, at the beginning of our research 
Benjamin and Neville were recorded as ‘adherent’ but within two years Benjamin was 
‘lost to follow-up’ (even though we and the care-workers knew where he was in a 
geographic sense), and he subsequently died. Meanwhile, Neville remained ‘adherent’ 
although his use of medication was less than ideal. Gabriella and Ophelia on the other 
hand, both went (in the view of the clinic) from ‘non-adherent’ to ‘adherent’ even though 
they presented quite different patterns of consistently partial use. Whatever else these 
observations demonstrate they show that neither ‘access’ nor ‘adherence’ is a state, 
something that someone has/does not have or is/is not doing. 
Instead, adherence is negotiated continuously, sometimes on a week-to-week basis – 
very often on grounds in-between ‘medical’ and ‘non-medical’ considerations, such as 
understandings of how ‘healthy’ one can be while still maintaining access to the social 
grant available to patients who are too sick to work.  In many settings in our fieldwork, 
for example, real unemployment rates are in excess of 80%, thus the ‘supplemental’ 
income provided by the government for some HIV sufferers represents a significant 
improvement in household budgets.  In the end, the picture that emerges is one in which 
HIV-positive individuals are often listed as ‘adherent’ when they are in fact experimenting 
with different schedules of ARVs, often while using complementary therapies in order 
to survive in circumstances that can be very close to overwhelming.  At the same time, 
many of the ‘non-adherent’ (and even some of those who are ostensibly ‘lost to follow-
up’) are still taking a significant amount of ARV medication.
There is of course a significant global risk in the widespread, but inconsistent, use of 
ARVs; that is the potential emergence of super-resistant strain(s) of HIV, something 
that could conceivably set the clock back to the early 1990s, or even the 1980s, for 
everybody.6 While we do not wish to underplay the extraordinary success of the South 
African scale-up of ART, even where there has been the most dedicated staffing and 
6  The introduction of fixed dose combination therapy in 2013 has been heralded as something that should assist 
with adherence, but we note that very few people with whom we interacted found the schedule of the drugs per se 
to be a significant barrier to adhering to their treatment regimen. If scheduling as such is decisive, however, then 
we would predict an even higher failure rate on second-line treatment.
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over long periods of time. This is precisely the sort of knowledge good, long-term 
ethnographic work generates. Living with HIV means living with and on ART, and such 
therapeutic citizenship is no less conflicted and ambivalent as ‘citizenship’ in any other 
collectivity. We require many more researchers who track between the people producing 
such categories of inclusion and exclusion and those who inhabit them (sometimes all of 
them) at very different scales and at different moments in time. Such work is necessary 
both to safeguard the enormous gains that have been made in the past decade or so and 
to protect against an unseen and unappreciated global experiment where potentially 
millions of bodies with sub-optimal ART unnecessarily (and in a public health sense, 
very dangerously) sicken with resistant new sub-types of the virus. It is also a critical 
piece in the puzzle to better understand how the three clean bureaucratic categories of 
‘adherent’, ‘non-adherent’, and ‘lost to follow-up’ ultimately fit the complex biosocial 
realities that we wish to both analyse and improve.
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‘hard’ data to measure ‘success’ and ‘sustainability’ such complex processes are recoded 
as discrete events, and significant decisions about programmes and populations ride on 
how these ‘moments’ are tabulated and analysed. As Biehl (2007:385) notes, ”Numbers 
and statistics are intensely political,” but the politics involved change over time and 
vary with the scale of the analysis. While this issue of the production of evidence has 
exercised scholars in Global Health for some time (see among many others, Pisani 
2009 and Kleinman et al. 2008 ), we feel that the explosive expansion, the life-long 
nature, and the high individual and population costs of failure of ART all argue that this 
perspective needs to be more centrally positioned in longer-term ethnographic research 
on ‘adherence’.  
In making this case, we have no desire to further remove HIV treatment from the rest 
of any health system in resource-poor settings; indeed we are arguing the opposite.  Both 
Harries et al (2006) and Bax et al. (2015), for example, convey some of the complexities 
of scaling up ART in resource poor settings, highlighting the need to ensure that other 
health services do not suffer in the attempts to improve HIV treatment.  It is clearly 
health systems that need investment and overall strengthening. This insight is becoming 
obvious in the renewed Global Health/International Health interest in the immense 
burden of chronic and non-communicable diseases in resource poor settings (e.g., 
Alwan 2010). This insight, though, should be more expressly connected with a large 
literature on how issues of governmentality and long-term connection with medication 
and/or repeat clinical visits exist in other contexts (Leonard, Greene and Erbelding 
2007, Saris 2008 and Montoya 2011, among many others). We would like to see the 
problem of ART adherence centrally positioned in this reinvigorated appreciation 
of health systems.  In a sense, this call harkens back to themes in Critical Medical 
Anthropology that never went away (see Baer, Singer and Susser 2013 [1993]), but now 
we now confront the remarkable (if still partial) success of sheer access to drugs, and the 
reality of the immense diversity of the complex social-moral worlds into which these 
pharmaceuticals have been woven on an unprecedented scale.   
To keep on top of this challenge, we will need to know a lot about a lot of things all at 
once – how people understand access to ART; but also much more precisely how they are 
taking their medication on a day-to-day through year-to-year basis, and, importantly, how 
they are monitored, especially, the specific mechanisms through which this knowledge 
is tabulated and disseminated. We will want to know about health services and health 
messages (and how to improve them), but we will also need to know how certain social-
medical issues like how alcohol exist in extremely complex ways in historical memory 
and local moral worlds (see Mfecane 2011).  We want to improve data-collection and 
analysis of health systems, but we need to understand the complexities of translation 
between communities of speech, language, class, and professional expertise (see Wood 
and Lambert 2008), as well as how this data is tabulated and scaled up in as fine-grained 
a way as is feasible.  Most importantly, we need to do this rigorously and consistently 
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